Technical Articles

重组人CD19蛋白背后的产业线:从自体 CAR-T 到通用型与双抗
The CD19 Industry Line: From Autologous CAR-T to Off-the-Shelf and Bispecifics
发布时间 2026-10-26
CD19 anchors the largest CAR-T franchise. This article walks the industry chain: autologous manufacturing, allogeneic and in-vivo formats, bispecifics and where antigen reagents fit in.
View details
  • Immunity/Inflamma
  • CD19 industry
  • CAR-T
  • bispecific antibody
  • off-the-shelf
  • potency assay
  • antigen reagent
  • UA011126
Total 1
  • 1
Go to